Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 23;12(5):528.
doi: 10.3390/healthcare12050528.

Clinical Course, Laboratory Findings, and Prognosis of SARS-CoV-2 Infection in Infants up to 90 Days of Age: A Single-Center Experience and a Proposal for a Management Pathway

Tommaso Bellini  1 , Giacomo Brisca  2 , Ioannis Orfanos  3   4 , Marcello Mariani  5 , Federico Pezzotta  6 , Benedetta Giordano  6 , Andrea Pastorino  6 , Silvia Misley  6 , Clelia Formigoni  6 , Elena Fueri  6 , Marta Ferretti  1 , Marta Marin  1 , Martina Finetti  1 , Emanuela Piccotti  1 , Elio Castagnola  5 , Andrea Moscatelli  2
Affiliations

Clinical Course, Laboratory Findings, and Prognosis of SARS-CoV-2 Infection in Infants up to 90 Days of Age: A Single-Center Experience and a Proposal for a Management Pathway

Tommaso Bellini et al. Healthcare (Basel). .

Abstract

Aim: To provide a comprehensive description of the clinical features, biochemical characteristics, and outcomes of infants up to 90 days old with COVID-19. Moreover, to assess the severity of the disease and propose an effective management pathway.

Methods: Retrospective single-center study spanning three years. Patient data includes age, sex, symptoms, comorbidities, blood and urine test results, cultures, admission, length of stay, therapies, intensive care unit admission, and mortality.

Results: A total of 274 patients were enrolled in the study, comprising 55% males. Among them, 60 patients (22%) were under the age of 29 days, while 214 (78%) fell within the 29 to 90 days age range. The overall incidence of SARS-CoV-2 infections was 0.28 per 10,000 Pediatric Emergency Department admissions. Blood inflammatory markers showed no significant abnormalities, and there were no recorded instances of positive blood cultures. Less than 1% of infants showed urinary tract infections with positive urine cultures, and 1.5% of patients had a concurrent RSV infection. Hospitalization rates were 83% for neonates and 67% for infants, with a median length of stay (LOS) of 48 h for both age groups. None of the patients required admission to the Pediatric or Neonatal Intensive Care Unit, and only one required High Flow Nasal Cannula (HFNC). No secondary serious bacterial infections were observed, and all hospitalized patients were discharged without short-term sequelae. No deaths were reported.

Discussion and conclusions: Infants with COVID-19 generally exhibit milder or asymptomatic forms of the disease, making home management a viable option in most cases. Blood tests, indicative of a mild inflammatory response, are recommended primarily for children showing symptoms of illness. Hospitalization precautions for infants without apparent illness or comorbidities are deemed unnecessary. Given the evolving nature of experiences with COVID-19 in infants, maintaining a high level of clinical suspicion remains imperative.

Keywords: COVID-19 epidemiology; clinical severity; febrile infant; pediatric emergency department; prognosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of the inclusion and exclusion criteria. PED = Pediatric Emergency Department; COVID-19 = CoronaVirus Disease 19.
Figure 2
Figure 2
Shows our proposed management pathway, summarizing the previous suggestions.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Venturini E., Montagnani C., Garazzino S., Donà D., Pierantoni L., Vecchio A.L., Nicolini G., Bianchini S., Krzysztofiak A., Galli L., et al. Treatment of children with COVID-19: Position paper of the Italian Society of Pediatric Infectious Disease. Ital. J. Pediatr. 2020;46:139. doi: 10.1186/s13052-020-00900-w. - DOI - PMC - PubMed
    1. Khoury L., Pillar G., Shehadeh S. COVID-19 in neonates and infants younger than 6 months—A mild viral illness. Eur. J. Pediatr. 2023;182:3287–3291. doi: 10.1007/s00431-023-05016-x. - DOI - PMC - PubMed
    1. Dona’ D., Montagnani C., Di Chiara C., Venturini E., Galli L., Vecchio A.L., Denina M., Olivini N., Bruzzese E., Campana A., et al. COVID-19 in Infants Less than 3 Months: Severe or Not Severe Disease? Viruses. 2022;14:2256. doi: 10.3390/v14102256. - DOI - PMC - PubMed
    1. Gale C., A Quigley M., Placzek A., Knight M., Ladhani S., Draper E.S., Sharkey D., Doherty C., Mactier H., Kurinczuk J.J. Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: A prospective national cohort study using active surveillance. Lancet Child Adolesc. Health. 2021;5:113–121. doi: 10.1016/S2352-4642(20)30342-4. - DOI - PMC - PubMed
    1. Kanburoglu M.K., Tayman C., Oncel M.Y., Akin I.M., Can E., Demir N., Arayici S., Baser D.O., Caner I., Memisoglu A., et al. A Multicentered Study on Epidemiologic and Clinical Characteristics of 37 Neonates With Community-acquired COVID-19. Pediatr. Infect. Dis. J. 2020;39:e297–e302. doi: 10.1097/INF.0000000000002862. - DOI - PubMed

LinkOut - more resources